Y-Intercept (HK)’s ResMed RMD Stock Holding History

Y-Intercept (HK)’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.34M	Sell	6,878 -13,373	-66%	-$2.77M	0.03%	908
2026 Q1	$4.55M	Buy	20,251 +6,426	+46%	+$1.6M	0.09%	353
2025 Q4	$3.33M	Buy	13,825 +5,105	+59%	+$1.31M	0.07%	378
2025 Q3	$2.39M	Buy	+8,720	New	+$2.38M	0.06%	509
2024 Q4	–	Sell	-843	Closed	-$206K	–	1585
2024 Q3	$206K	Sell	843 -6,375	-88%	-$1.42M	0.01%	1157
2024 Q2	$1.38M	Buy	+7,218	New	+$1.46M	0.08%	364
2024 Q1	–	Sell	-5,466	Closed	-$940K	–	1698
2023 Q4	$940K	Buy	+5,466	New	+$840K	0.09%	341
2023 Q2	–	Sell	-3,725	Closed	-$816K	–	1656
2023 Q1	$816K	Sell	3,725 -1,802	-33%	-$391K	0.09%	316
2022 Q4	$1.15M	Buy	+5,527	New	+$1.21M	0.17%	166
2022 Q1	–	Sell	-1,292	Closed	-$337K	–	916
2021 Q4	$337K	Sell	1,292 -5,547	-81%	-$1.44M	0.08%	363
2021 Q3	$1.8M	Buy	+6,839	New	+$1.87M	0.33%	79
2021 Q1	–	Sell	-1,136	Closed	-$238K	–	771
2020 Q4	$238K	Buy	+1,136	New	+$227K	0.1%	394

Other funds holding RMD

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Vest Financial Mclean, Virginia $9.52B AUM 31.6% 1-Year Est. Return

Arbejdsmarkedets Tillaegspension Hilleroed $4.6B AUM

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

CISOA

Capital Investment Services of America Milwaukee, Wisconsin $1.02B AUM 3.04% 1-Year Est. Return

DJSG

D.J. St. Germain Springfield, Massachusetts $2.78B AUM 23.87% 1-Year Est. Return

MIF

Mediolanum International Funds Dublin 1, Ireland $11.7B AUM 47.18% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

CIM

Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Y-Intercept (HK)'s RMD Position: Q2 2026 in Review

Y-Intercept (HK) reduced its ResMed (RMD) stake by 66% in Q2 2026, selling an estimated $2.77M and leaving 6,878 shares worth $1.34M. The position accounts for 0.03% of the portfolio, ranked #908.

Y-Intercept (HK) first reported a position in RMD in Q4 2020 and has held it in 12 quarters since. The position peaked at $4.55M in Q1 2026. 206 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

Y-Intercept (HK) held 6,878 shares of ResMed worth $1.34M as of Q2 2026.
Y-Intercept (HK) sold 13,373 ResMed shares in Q2 2026, an estimated $2.77M.
ResMed made up 0.03% of Y-Intercept (HK)'s portfolio in Q2 2026, its #908 holding.
Y-Intercept (HK) first reported a position in ResMed in Q4 2020 and has held it in 12 quarters since.
Y-Intercept (HK)'s ResMed position peaked at $4.55M in Q1 2026.
206 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Y-Intercept (HK)'s 13F filing for Q2 2026, filed 14 Jul 2026.